tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Technical Analysis

Compare
586 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Phathom Pharmaceuticals’s (PHAT) Moving Averages Convergence Divergence (MACD) indicator is -0.60, suggesting Phathom Pharmaceuticals is a Sell.
Phathom Pharmaceuticals’s (PHAT) 20-Day exponential moving average is 12.42, while Phathom Pharmaceuticals’s (PHAT) share price is $11.05, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) 50-Day exponential moving average is 13.33, while Phathom Pharmaceuticals’s (PHAT) share price is $11.05, making it a Sell.

Phathom Pharmaceuticals (PHAT) Pivot Points

Mar 04, 2026, 09:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.26
10.85
11.15
11.74
12.05
12.64
12.94
Fibonacci
10.85
11.19
11.40
11.74
12.08
12.29
12.64
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Phathom Pharmaceuticals (PHAT) Moving Averages

Mar 04, 2026, 09:15 PM
Period
Simple
Exponential
MA5
12.19Sell
11.78Sell
MA10
11.92Sell
12.00Sell
MA20
12.29Sell
12.42Sell
MA50
14.20Sell
13.33Sell
MA100
14.11Sell
13.23Sell
MA200
11.75Sell
11.16Sell
Phathom Pharmaceuticals’s (PHAT) 10-Day exponential moving average is 12.00, while Phathom Pharmaceuticals’s (PHAT) share price is $11.05, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) 100-Day exponential moving average is 13.23, while Phathom Pharmaceuticals’s (PHAT) share price is $11.05, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) stock price is $11.05 and Phathom Pharmaceuticals’s (PHAT) 50-day simple moving average is 14.20, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $11.05 and Phathom Pharmaceuticals’s (PHAT) 100-day simple moving average is 14.11, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $11.05 and Phathom Pharmaceuticals’s (PHAT) 200-day simple moving average is 11.75, creating a Sell signal.

Phathom Pharmaceuticals (PHAT) Technical Indicators

Mar 04, 2026, 09:15 PM
Name
Value
Implied Action
RSI (14)
38.15
Neutral
STOCH (9,6)
23.11
Neutral
STOCHRSI (14)
23.11
Neutral
MACD (12,26)
-0.60
Sell
ADX (14)
18.76
Buy
Williams %R
-90.27
Buy
CCI (14)
-144.56
Buy
ATR (14)
0.98
-
Ultimate Oscillator
43.65
Neutral
ROC
-13.81
Sell
Phathom Pharmaceuticals’s (PHAT) Relative Strength Index (RSI) is 38.15, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Trend Strength Indicator (ADX) is 18.76, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Commodity Channel Index (CCI) is -144.56, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Price Rate of Change (ROC) is -13.81, creating a Sell signal.

FAQ

Is PHAT a Buy, Hold, or Sell?
Based on PHAT’s technical indicators, PHAT is a Strong Sell.
    What is PHAT’s RSI (14)?
    PHAT’s RSI (14) is 38.15, which suggests PHAT is a Neutral.
      What is PHAT’s MACD?
      PHAT’s MACD is -0.60, which suggests PHAT is a Sell.
        What is PHAT’s 5-day moving average?
        PHAT’s 5-day moving average is 12.19, which suggests PHAT is a Sell.
          What is PHAT’s 20-day moving average?
          PHAT 20-day moving average is 12.29, which suggests PHAT is a Sell.
            What is PHAT’s 50-day moving average?
            PHAT’s 50-day moving average is 14.20, which suggests PHAT is a Sell.
              What is PHAT’s 200-day moving average?
              PHAT’s 200-day moving average is 11.75, which suggests PHAT is a Sell.
                What is PHAT’s Williams % R (14)?
                PHAT’s Williams % R (14) is -90.27, which suggests PHAT is a Buy.
                  What is PHAT’s CCI (14)?
                  PHAT’s CCI (14) is -144.56, which suggests PHAT is a Buy.